148 related articles for article (PubMed ID: 22470775)
1. Orbital plasmablastic lymphoma with remission following chemotherapy.
Degnan AJ; Levy LM
J Radiol Case Rep; 2011; 5(2):1-7. PubMed ID: 22470775
[TBL] [Abstract][Full Text] [Related]
2. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
Morley AM; Verity DH; Meligonis G; Rose GE
Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
[TBL] [Abstract][Full Text] [Related]
3. Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support.
Cabanillas F; Cotto M; Liboy I; Rivera E; Pavia OA; Bruno M
Leuk Lymphoma; 2012 Oct; 53(10):1929-33. PubMed ID: 22448918
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous plasmablastic lymphoma.
Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Castillo JJ; Reagan JL; Sikov WM; Winer ES
Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
[TBL] [Abstract][Full Text] [Related]
6. Orbital manifestations of B-cell acute lymphoblastic leukemia/lymphoma.
Strawbridge JC; Roelofs KA; Naderi J; Goh TY; Rootman DB
Orbit; 2023 Dec; 42(6):654-658. PubMed ID: 35580237
[TBL] [Abstract][Full Text] [Related]
7. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature.
Ely A; Evans J; Sundstrom JM; Malysz J; Specht CS; Wilkinson M
Orbit; 2012 Aug; 31(4):267-9. PubMed ID: 22681504
[TBL] [Abstract][Full Text] [Related]
8. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
Coupland SE
Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
[TBL] [Abstract][Full Text] [Related]
9. An aggressive primary orbital natural killer/T-cell lymphoma case: poor response to chemotherapy.
Marchino T; Ibáñez N; Prieto S; Novelli S; Szafranska J; Mozos A; Graell X; Buil JA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):e131-4. PubMed ID: 24317101
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
11. Blurred Vision and Wrinkled Retinas in an Elderly Man.
Zhao PY; Kahana A; Kim TN
JAMA Ophthalmol; 2019 Feb; 137(2):226-227. PubMed ID: 30589928
[No Abstract] [Full Text] [Related]
12. Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapy.
Jayachandran PK; Rajan AK; Karunakaran P; Mehra N; Selvarajan G; Kesana S; Dhanushkodi M; Radhakrishnan V; Sagar TG
Leuk Res; 2020 Aug; 95():106391. PubMed ID: 32559556
[TBL] [Abstract][Full Text] [Related]
13. Primary Maxillary Sinus Plasmablastic Lymphoma in HIV/AIDS.
Basavaraj A; Kadam M; Kadam DB
J Assoc Physicians India; 2016 May; 64(5):71-72. PubMed ID: 27735156
[TBL] [Abstract][Full Text] [Related]
14. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Dissemination from an Orbital Diffuse Large B Cell Lymphoma.
Bains S; Vidhya N; Kim U; Shanti R; Devanand J
Orbit; 2015; 34(6):338-9. PubMed ID: 26452055
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the conjunctiva invading the orbit in a non-Hodgkin lymphoma.
Kwon SI; Chung YS; Kim YJ
Jpn J Ophthalmol; 2009 Nov; 53(6):650-651. PubMed ID: 20020247
[No Abstract] [Full Text] [Related]
18. Cure in a case of primary hepatic lymphoma.
Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
[TBL] [Abstract][Full Text] [Related]
19. Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient.
Mihaljevic BS; Todorovic MR; Andjelic BM; Antic DA; Perunicic Jovanovic MD
Med Oncol; 2012 Jun; 29(2):1186-9. PubMed ID: 21476144
[TBL] [Abstract][Full Text] [Related]
20. A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma.
Wilder DD; Ogden JL; Jain VK
Clin Lymphoma; 2001 Mar; 1(4):285-92. PubMed ID: 11707843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
